TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
PERF

Perfect Corp.

Technology · Software - Application

1.90$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PERF
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025
– +0.5% -2.5% +1.0% +46.3% +0.9% -8.8% -9.1% -11.6% – – +93.9% +3.1% +136.5% -19.0% +6.3% +6.0%
– -4.2% +0.3% -3.3% +28.1% +5.3% -11.2% -10.1% -9.8% – – +96.5% +3.0% +139.1% -19.4% +5.5% -2.6%
– -70.0% -36.6% +36.1% +45.5% -36.5% -1.3% +267.9% +32.5% – – +179.4% +1.8% +102.1% -23.8% +2.6% -0.9%
– -70.0% -36.6% +36.1% +45.5% -36.5% -1.3% +267.9% +32.5% – – +119.0% +1.8% +139.4% -20.0% +7.6% -2.2%
– -21.9% -20.0% -13.0% +15.5% +68.4% -19.2% +6.6% -13.6% – – -11.3% +20.5% +77.9% -11.8% -8.8% -6.2%
– +14.4% +4.0% -3.5% +25.4% +4.0% -10.4% -12.6% -11.2% – – -8.3% +0.0% -48.9% -26.7% -45.5% -5.6%
– – – – – – – – – – – -0.1% +33.2% -40.4% – – –
– – – – – +0.0% +0.0% +0.0% +0.0% – – – – – – – –
– – – – – -26.8% -17.3% -24.4% -27.2% – – +71.2% -11.5% +19.0% -35.3% -58.4% +5,046.9%
– +16.2% -1.0% -7.5% +42.6% +4.9% -12.4% -8.2% -6.4% – – +85.8% +129.0% -89.9% +9.4% +10.3% +13.8%
– +217.1% -54.7% +6.6% +27.8% +4.8% -18.1% -2.8% -11.0% – – +48.0% +48.5% +25.9% +16.0% +11.5% +16.9%
– – -41.7% +202.7% -22.6% +2.3% +23.5% +13.0% -0.9% – – -8.9% +99.6% -44.1% +91.6% -16.4% +10.4%
– +21.6% -26.4% +15.7% +49.6% +12.8% -22.0% -18.1% -11.1% – – +4,824.2% +22.4% – – – –
– -20.9% -5.6% +7.1% +59.1% -11.5% +4.4% -11.9% -28.0% – – – – – -23.4% +5.5% +4.1%
– -146.8% – – – – – – – – – – – – – – –
– +2,245.1% +0.0% +0.7% +54.4% -86.2% +706.9% 0.0% +0.0% -4.6% +0.0% +0.0% +0.0% +0.0% -0.2% -14.9% -7.5%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?